« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 1
, Pages 3-5
, 1 January 2006
Radiation-enhanced immune response to cancer: Workshop, Anaheim, CA, April 17, 2005
References
- Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer . Cancer Res . 1999;59:6028–6032
- Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated . Int J Radiat Oncol Biol Phys . 2004;58:862–870
- External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing . Cancer Res . 2004;64:4328–4337
- Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes . Cancer Res . 2004;64:7985–7994
-
Immune-mediated inhibition of metastases following treatment with local radiation and CTLA-4-blockade in a mouse model of breast cancer
.
Clin Cancer Res
. 2005;11:1–7
- CpG oligodeoxynucleotide enhances tumor response to radiation . Cancer Res . 2004;64:5074–5077
- Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy . Clin Cancer Res . 2005;11:361–369
- Adjuvant therapy for melanoma in dogs (Clinical trials using surgery, liposome-encapsulated muramyl tripeptide and granulocyte macrophage colony-stimulating factor) . Clin Cancer Res . 1999;5:4249–4258
- . Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses . Clin Cancer Res . 2005;11:2416–2426
- Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor . J Immunol . 2005;174:7516–7523
- Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells . J Immunol . 2004;173:2462–2469
Workshop participants: Silvia Formenti (New York University), Chandan Guha (Einstein/Montefiore), Jeffrey Schlom (National Cancer Institute [NCI]), William McBride (University of California-Los Angeles), Howard Streicher (NCI), Luka Milas (M. D. Anderson Cancer Center), Douglas Thamm (Colorado State University [CSU]), Richard Morse (Varian Medical Systems), David Vail (CSU), Robert Sutherland (Varian Biosynergy), and Dennis Panical (Therion Biologics).
PII: S0360-3016(05)02581-2
doi: 10.1016/j.ijrobp.2005.08.036
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 1
, Pages 3-5
, 1 January 2006
